AbbVie Options Price In a Sudden 5% Swing—What Investors Must Know Before Oct. 30

AbbVie (NYSE:ABBV) reports third-quarter results before the open on October 30. Shares are up 28.55% year to date, and options pricing implies a roughly 5% move on the release. That leaves little room for a stumble. Big Momentum Meets a Guidance Trim Last quarter, AbbVie posted adjusted EPS of $3.65 on revenue of $16.99 billion, […]